In the case of IL-4, a significant increase in its concentration was observed in patients with CHD (1.26 times higher), and a decrease was observed in patients with CTEPH (1.63 times) and IPAH (2.68 times) compared with healthy volunteers. Here, IL4 is linked to chronic thromboembolic pulmonary hypertension.